OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026
Rhea-AI Summary
OPKO Health (NASDAQ: OPK) will report first quarter 2026 operating and financial results for the period ended March 31, 2026 after market close on April 28, 2026.
Management will host a conference call and live audio webcast on April 28 at 4:30 p.m. Eastern to discuss results and financial guidance. Telephone replay and webcast replay will be available through early May.
Positive
- None.
Negative
- None.
News Market Reaction – OPK
In the Apr 22 session, OPK gained 0.82%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 12 | Earnings date set | Neutral | -3.2% | Announced date and call details for Q4 2025 results and guidance. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
The last earnings date announcement on Feb 12, 2026 was followed by a -3.2% move, indicating prior sensitivity around scheduling earnings updates.
Over recent months, OPKO has combined pipeline progress with financial resets. On Feb 26, 2026, it reported Q4 2025 revenue of $148.5M vs. $183.6M a year earlier and a net loss of $31.3M, alongside 2026 revenue guidance of $530–$560M. Earlier, an earnings date notice on Feb 12, 2026 preceded a -3.2% move. The latest announcement simply schedules Q1 2026 results and a business update, continuing the established cadence of quarterly communications.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, April 21, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2026 after the close of the U.S. financial markets on Tuesday, April 28, 2026. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on April 28th beginning at 4:30 p.m. Eastern time.
CONFERENCE CALL & WEBCAST INFORMATION
OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed at OPKO’s Investor Relations page and here.
A telephone replay will be available until May 5, 2026, by dialing 855-669-9658 (U.S.) or 412-317-0088 (International) and providing the passcode 2140261. A webcast replay will be available beginning approximately one hour after the completion of the live conference call here.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
Alliance Advisors IR
Yvonne Briggs, 310-691-7100
ybriggs@allianceadvisors.com
or
Bruce Voss, 310-691-7100
bvoss@allianceadvisors.com
